Assignee
GENESTE HERVE
DE·6 granted patents·4 pending applications·11 citations·filing 2001–2012
Top patents by PatentIndex Score
10 records- 0183US9938269B2Inhibitor compounds of phosphodiesterase type 10AGENESTE HERVE·Filed 2012·Granted Apr 10, 2018·7 cites·33 claims
- 0277US9242933B2Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)GENESTE HERVE·Filed 2008·Granted Jan 26, 2016·3 cites·18 claims
- 0368US8431567B2Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligandsGENESTE HERVE·Filed 2007·Granted Apr 30, 2013·1 cites·22 claims
- 0459US2010048536A1Novel Substituted Diaryl Azepine Derivatives as Integrin LigandsGENESTE HERVE·Filed 2009·Application pending·0 cites
- 0555US2006159678A1Modulators of cytokine mediated signaling pathways and integrin alphabeta3 receptor antagonists for combination therapyGENESTE HERVE·Filed 2006·Application pending·0 cites
- 0652US2012003229A1Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapyGENESTE HERVE·Filed 2011·Application pending·0 cites
- 0749US8114875B2Substituted N-heterocyclic compounds and their use as dopamine D3 receptor ligandsGENESTE HERVE·Filed 2005·Granted Feb 14, 2012·0 cites·9 claims
- 0847US8334289B2Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptorGENESTE HERVE·Filed 2011·Granted Dec 18, 2012·0 cites·17 claims
- 0945US8268815B2Pyrimidine compounds and use thereofGENESTE HERVE·Filed 2010·Granted Sep 18, 2012·0 cites·15 claims
- 1038US2008221082A1Ligands of Integrin ReceptorsGENESTE HERVE·Filed 2001·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →